Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    "Shigellosis"
Show Display Options
Download search resultsDownload the search results for:
"Shigellosis" (31 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Withdrawn Shigella Sonnei OSPC-rDT Conjugate Vaccine
Condition: Shigellosis
Intervention: Drug: CP
2 Completed A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.
Condition: Shigellosis
Interventions: Biological: S. sonnei 1790GAHB;   Biological: Placebo
3 Completed Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults
Condition: Shigellosis
Interventions: Biological: S. sonnei 1790GAHB;   Biological: Placebo
4 Completed Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a
Condition: Shigellosis
Interventions: Biological: Flexyn2a;   Biological: Placebo;   Biological: Flexyn2a plus adjuvant
5 Completed Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults
Condition: Shigellosis
Intervention: Biological: Shigella flexneri 2a whole cell killed vaccine (Sf2aWC)
6 Completed
Has Results
Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel
Condition: Shigellosis
Intervention: Biological: Shigella conjugate vaccines
7 Completed Shigella Sonnel O-SPC/rBRU Conjugate Vaccine
Conditions: Immunogenicity;   Shigellosis
Intervention: Biological: Shigella Sonnei O-SPC/rBRU
8 Completed Therapeutic Induction of Endogenous Antibiotics
Condition: Shigellosis
Interventions: Biological: Sodium Butyrate;   Biological: Saline
9 Recruiting Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Administered Intranasally to Healthy, Adult Volunteers
Conditions: Shigellosis;   Bacillary Dysentery
Intervention: Biological: Shigella flexneri 2a InvaplexAR
10 Completed Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3
Condition: Shigella Infection
Interventions: Biological: WRSs2;   Biological: WRSs3;   Other: Placebo
11 Completed The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study
Condition: Shigella Sonnei Infection
Intervention: Other: Shigella sonnei infection
12 Completed Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
Condition: Shigellosis
Intervention: Biological: Invaplex 50 Vaccine
13 Completed Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella
Condition: Shigellosis
Intervention: Biological: Shigella vaccine
14 Completed Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP
Condition: Shigella
Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine;   Other: Placebo
15 Terminated Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb
Condition: Shigella
Intervention: Biological: CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
16 Terminated Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
Condition: Shigella
Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine;   Other: Placebo
17 Active, not recruiting Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a
Condition: Shigellosis
Interventions: Biological: Flexyn2a;   Biological: Placebo
18 Recruiting A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
Condition: Shigella Sonnei Infection
Interventions: Biological: S. sonnei vaccine 25 μg;   Biological: S. sonnei vaccine 100 μg;   Biological: Menveo;   Biological: Boostrix
19 Completed Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine
Condition: Shigella Infection
Intervention: Biological: SC599
20 Not yet recruiting SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers
Conditions: Shigellosis;   Bacillary Dysentery
Interventions: Biological: SF2a-TT15 vaccine;   Biological: SF2a-TT15 vaccine + adjuvant;   Biological: Placebo;   Biological: Placebo + adjuvant

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.